Dicloxacillin sodium capsules are indicated for the treatment of infections caused by penicillinase-producing staphylococci, which have demonstrated susceptibility to the drug.
Comments to the Centers for Medicare & Medicaid Services call for enforcement of electronic prescribing of controlled substances requirements no later than Jan. 1, 2023.
The Association for Accessible Medicines has released its 2022 U.S. Generic & Biosimilar Medicines Savings report highlighting the value of generic and biosimilar medicines.